On the stock market since 2009, it operates in the world of health and science. It has 26 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Average growth of 44% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
An investor who bought at the very peak is down 89% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
A loss of $1.9M against $533K in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.03. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, AVCRF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: AVCRF is a small company that closed last year at a loss. The road back to profit runs through spending discipline.